Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease

Proteomics

Volumn 9, Issue 14, 2009, Pages 3775-3782

  Lai, Xianyin ^a   Blazer Yost, Bonnie L ^a,b   Gattone II, Vincent H ^a   Muchatuta, Monalisa N ^b   Witzmann, Frank A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Autosomal recessive polycystic kidney disease; LC MS MS; Liver cyst fluid

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; BETA ACTIN; BETA2 GLYCOPROTEIN 1; CATALASE; CATHEPSIN B; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR D; COMPLEMENT FACTOR H; CYSTATIN C; ENOLASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FETUIN; FIBRINOGEN; FIBRONECTIN; HEAT SHOCK PROTEIN; HEMOGLOBIN; HEMOPEXIN; OROSOMUCOID; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SMOOTH MUSCLE ACTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BASEMENT MEMBRANE; BILE DUCT CYST; CELL PROLIFERATION; DISEASE COURSE; INFLAMMATORY CELL; KIDNEY POLYCYSTIC DISEASE; LIQUID CHROMATOGRAPHY; LIVER CYST; LIVER FIBROSIS; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS;

ANIMALS; CHROMATOGRAPHY, LIQUID; CYSTS; DISEASE MODELS, ANIMAL; LIVER; MICE; MICE, INBRED BALB C; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; TANDEM MASS SPECTROMETRY;

ANIMALIA; MUS;

EID: 68049090011     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800379     Document Type: Article

References (38)

1. Torres, V. E., Harris, P. C., Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat. Clin. Pract. 2006, 2, 40-55.
2. Davidow, C. J., Maser, R. L., Rome, L. A., Calvet, J. P., Grantham, J. J., The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int. 1996, 50, 208-218.
3. Muchatuta, M. N., Gattone V. H., II, Witzmann, F. A., Blazer-Yost, B. L., Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease. Exp. Biol. Med. (Maywood) 2009, 234, 17-27.
4. Ricker, J. L., Gattone V. H., II, Calvet, J. P., Rankin, C. A., Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice. J. Am. Soc. Nephrol. 2000, 11, 1837-1847.
5. Kaplan, R. S., Pedersen, P. L., Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal. Biochem. 1985, 150, 97-104.
6. Granger, J., Siddiqui, J., Copeland, S., Remick, D., Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 2005, 5, 4713-4718.
7. Zolotarjova, N., Martosella, J., Nicol, G., Bailey, J., et al., Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5, 3304-3313.
8. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
9. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
10. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2, 1096-1103.
11. Nichols, M. T., Gidey, E., Matzakos, T., Dahl, R. et al., Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 2004, 40, 836-846.
12. Farina, A., Dumonceau, J. M., Frossard, J. L., Hadengue, A. et al., Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J. Proteome Res. 2009, 8, 159-169.
13. Guerrier, L., Claverol, S., Finzi, L., Paye, F. et al., Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. J. Chromatogr. A 2007, 1176, 192-205.
14. Kristiansen, T. Z., Bunkenborg, J., Gronborg, M., Molina, H. et al., A proteomic analysis of human bile. Mol. Cell. Proteomics 2004, 3, 715-728.
15. Zhou, H., Chen, B., Li, R. X., Sheng, Q. H. et al., Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun. Mass Spectrom. 2005, 19, 3569-3578.
16. Lai, X. Y., Bacalla, R. L., Blazer-Yost, B. L., Hong, D. et al., Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin. Appl. 2008, 2, 1140-1152.
17. Valkova, N., Yunis, R., Mak, S. K., Kang, K., Kultz, D., Nek8 mutation causes overexpression of galectin-1, sorcin, and vimentin and accumulation of the major urinary protein in renal cysts of jck mice. Mol. Cell. Proteomics 2005, 4, 1009-1018.
18. Han, C. L., Chien, C. W., Chen, W. C., Chen, Y. R. et al., A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease. Mol. Cell. Proteomics 2008, 7, 1983-1997.
19. Hanaoka, K., Guggino, W. B., cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J. Am. Soc. Nephrol. 2000, 11, 1179-1187.
20. Ye, M., Grant, M., Sharma, M., Elzinga, L. et al., Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J. Am. Soc. Nephrol. 1992, 3, 984-994.
21. Riera, M., Burtey, S., Fontes, M., Transcriptome analysis of a rat PKD model: importance of genes involved in extracellular matrix metabolism. Kidney Int. 2006, 69, 1558-1563.
22. Murray, S. L., Grubman, S. A., Perrone, R. D., Rojkind, M. et al., Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease. Connect Tissue Res. 1996, 33, 249-256.
23. Baker, A. H., Edwards, D. R., Murphy, G., Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 2002, 115, 3719-3727.
24. Tiggelman, A. M., Boers, W., Moorman, A. F., de Boer, P. A. et al., Localization of alpha 2-macroglobulin protein and messenger RNA in rat liver fibrosis: evidence for the synthesis of alpha 2-macroglobulin within Schistosoma mansoni egg granulomas. Hepatology 1996, 23, 1260-1267.
25. Adams, J. C., Watt, F. M., Regulation of development and differentiation by the extracellular matrix. Development 1993, 117, 1183-1198.
26. Yang, F., Chen, Z. L., Bergeron, J. M., Cupples, R. L., Friedrichs, W. E., Human alpha 2-HS-glycoprotein/bovine fetuin homologue in mice: identification and developmental regulation of the gene. Biochim. Biophys. Acta 1992, 1130, 149-156.
27. Gattone, V. H., Ricker, J. L., Trambaugh, C. M., Klein, R. M., Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease. Kidney Int. 2002, 62, 1560-1569.
28. Gattone V. H., II, Lowden, D. A., Cowley, B. D., jr., Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice. Dev. Biol. 1995, 169, 504-510.
29. Hidaka, S., Kranzlin, B., Gretz, N., Witzgall, R., Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries. Cell Tissue Res. 2002, 310, 289-296.
30. Cowley, B. D., jr., Ricardo, S. D., Nagao, S., Diamond, J. R., Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int. 2001, 60, 2087-2096.
31. Zhou, H., Pisitkun, T., Aponte, A., Yuen, P. S. et al., Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006, 70, 1847-1857.
32. Devitt, A., Moffatt, O. D., Raykundalia, C., Capra, J. D. et al., Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998, 392, 505-509.
33. Abraham, L. J., Bradshaw, A. D., Shiels, B. R., Northemann, W. et al., Hepatic transcription of the acute-phase alpha 1-inhibitor III gene is controlled by a novel combination of cis-acting regulatory elements. Mol. Cell. Biol. 1990, 10, 3483-3491.
34. Chang, K., Pastan, I., Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc. Natl. Acad. Sci. USA 1996, 93, 136-140.
35. Xu, L. G., Li, L. Y., Shu, H. B., TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J. Biol. Chem. 2004, 279, 17278-17282.
36. Khaitlina, S. Y., Functional specificity of actin isoforms. Int. Rev. Cytol. 2001, 202, 35-98.
37. Sood, R., Wong, W., Gotlib, J., Jeng, M., Zehnder, J. L., Gene expression and pathway analysis of immune thrombocytopenic purpura. Br. J. Haematol. 2008, 140, 99-103.
38. Ogborn, M. R., Polycystic kidney disease - a truly pediatric problem. Pediatr. Nephrol. 1994, 8, 762-767.